Bassia scoparia (commonly known as Kochia or burning bush) has a long history of use in traditional Chinese medicine, primarily for its diuretic, anti-inflammatory, and anti-pruritic properties. In traditional practices, it has been used to treat conditions such as urinary tract infections, skin diseases, and sometimes respiratory issues, but its use for Chronic Obstructive Pulmonary Disorder (COPD) is not a central or well-documented part of its traditional application. The attribution of benefit for COPD seems to arise more from generalized claims about its anti-inflammatory and expectorant effects rather than direct historical use for COPD specifically.

Scientifically, there is very limited evidence supporting the use of Bassia scoparia for COPD. Most available studies focus on its anti-inflammatory, antioxidant, and immunomodulatory properties in cell or animal models, but none provide direct clinical evidence or robust preclinical data specific to COPD. Reviews and pharmacological summaries mention its potential for reducing inflammation, which is a component of COPD pathophysiology, but these are not substantiated by clinical trials or high-quality studies in humans with COPD.

In summary, the use of Bassia scoparia for COPD is rooted in traditional medicine, with some theoretical rationale based on its general pharmacological effects, but lacks substantial scientific validation or clinical evidence for this particular condition.